Clinical trial Recruiting at 5 sites Observational Ages 18 and up

Comparing 3D and 2D heart strain measurements in heart failure patients

Official title: Left Ventricular Myocardial Strain Assessed by Three-dimensional Speckle-tracking Echocardiography in Heart Failure With Reduced and Mildly Reduced Ejection Fraction. A Comparison With Two-dimensional Evaluation in a Prospective Study

Run by Istituti Clinici Scientifici Maugeri SpA · NCT07741305 · Data updated 2026-11-12

This study tests whether 3D speckle-tracking echocardiography provides different or better information than 2D in assessing heart muscle function in people with heart failure and reduced or mildly reduced ejection fraction.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment419 (estimated)
SponsorIstituti Clinici Scientifici Maugeri SpA
Academic / other
Locations5 sites (Bari, BA and 4 other locations)
StatusRecruiting
StartedJanuary 8, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 19, 2026
Trial IDNCT07741305 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with heart failure and LVEF ≤ 49% who can undergo echocardiography with adequate image quality at participating Italian centers.

Probably not a fit

Patients with poor acoustic windows, significant arrhythmias preventing multi-beat imaging, or inability to consent may not benefit from these findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling about 419 adults with heart failure across seven Italian cardiac centers to compare left-ventricular strain measurements from 2D and 3D speckle-tracking echocardiography. Researchers will use standardized equipment and software to determine how closely the two methods agree and what factors influence any differences. The study will also explore whether 3D GLS better predicts mortality risk than 2D GLS. Inclusion requires LVEF ≤ 49% and adequate image quality; several image-acquisition limitations are excluded. No interventions are administered; the study analyzes imaging data collected during routine care.

Why it matters

Potential benefit: If 3D GLS proves more predictive, clinicians may improve risk stratification and management decisions for heart failure patients.

How similar studies have gone: Prior research supports 2D GLS for prognosis in heart failure, with 3D GLS showing potential advantages but limited comparative data in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Left ventricular ejection fraction (LVEF) ≤ 49%;
* Echocardiographic image quality judged to be at least adequate according to a four-point visual image quality scale (good, adequate, poor, or inadequate)

Exclusion Criteria:

* Inability to maintain the correct position for acquiring echocardiographic images;
* Arrhythmias that make multi-beat acquisition impossible (if required), such as frequent extrasystoles (supraventricular or ventricular) and atrial fibrillation;
* Failure to visualize more than 2 segments of the left ventricle (LV), or inability to assess more than 3 segments during 3D GLS analysis;
* Failure to sign the informed consent form and inability of the participant to understand the objectives of the study

Where it's running

  • ICS Maugeri - Istituto di Bari
    Bari, Ba, Italy
    Recruiting
  • ICS Maugeri - Istituto di Milano
    Milan, Mi, Italy
    Recruiting
  • ICS Maugeri - Istituto di Pavia
    Pavia, Pv, Italy
    Recruiting
  • ICS Maugeri Torino
    Torino, To, Italy
    Recruiting
  • ICS Maugeri - Istituto di Veruno
    Veruno, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.